Bitter Roots电子书

售价：¥

2人正在读 | 0人评论

9.8

作者：Osseo-Asare, Abena Dove

出版社：University of Chicago Press

出版时间：2014-01-13

字数：62.2万

所属分类：进口书 > 外文原版书 > 文学/自传/回忆录

温馨提示：数字商品不支持退换货，不提供源文件，不支持导出打印

为你推荐

哈利·波特与被诅咒的孩子(第一部和第二部):伦敦西区原创舞台剧的官方剧本

￥25.00

Elon Musk: Moving the World One Technology at a Time

￥24.44

Think Like a Spy: 12 Basic Facts You Must Know about Espionage

￥24.44

Elon Musk

￥95.11
Whimsical Words and Dramatic Affairs

￥0.01

Money Matters Bitcoin Buzz Report

￥0.01

House, M.D. 豪斯医生官方指南

￥105.17

The Guardian Herd: Stormbound

￥39.13

读书简介
目录
累计评论(0条)

读书简介
目录
累计评论(0条)

For over a century, plant specialists worldwide have sought to transform healing plants in African countries into pharmaceuticals. And for equally as long, conflicts over these medicinal plants have endured, from stolen recipes and toxic tonics to unfulfilled promises of laboratory equipment and usurped personal patents. In Bitter Roots, Abena Dove Osseo-Asare draws on publicly available records and extensive interviews with scientists and healers in Ghana, Madagascar, and South Africa to interpret how African scientists and healers, rural communities, and drug companies-including Pfizer, Bristol-Myers Squibb, and Unilever-have sought since the 1880s to develop drugs from Africa's medicinal plants.?Osseo-Asare recalls the efforts to transform six plants into pharmaceuticals: rosy periwinkle, Asiatic pennywort, grains of paradise, Strophanthus, Cryptolepis, and Hoodia.?Through the stories of each plant, she shows that herbal medicine and pharmaceutical chemistry have simultaneous and overlapping histories that cross geographic boundaries. At the same time, Osseo-Asare sheds new light on how various interests have tried to manage the rights to these healing plants and probes the challenges associated with assigning ownership to plants and their biochemical components.A fascinating examination of the history of medicine in colonial and postcolonial Africa, Bitter Roots will be indispensable for scholars of Africa; historians interested in medicine, biochemistry, and society; and policy makers concerned with drug access and patent rights.

目录展开